Triple-negative breast cancer: Neoadjuvant durvalumab improves prognosis

被引：0
|
作者：
Kunzell, Judith Lorenz
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
D O I：
10.1055/a-1985-2104
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Eine vielversprechende Therapiestrategie beim fruhen Mammakarzinom ist die Gabe von Immuncheckpoint-Inhibitoren zusatzlich zur neoadjuvanten Chemotherapie. Die GeparNuevo-Studie prufte bei Frauen mit einem triple-negativen Tumor den PD-L1-(Programmed Death-Ligand 1-)Inhibitor Durvalumab zusatzlich zur anthrazyklin-/taxanbasierten Zytostase gegen Placebo. Nun liegen die Ergebnisse zu den sekundaren uberlebensendpunkten vor.
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
    Loibl, S.
    Schneeweiss, A.
    Huober, J.
    Braun, M.
    Rey, J.
    Blohmer, J. U.
    Furlanetto, J.
    Zahm, D. M.
    Hanusch, C.
    Thomalla, J.
    Jackisch, C.
    Staib, P.
    Link, T.
    Rhiem, K.
    Solbach, C.
    Fasching, P. A.
    Nekljudova, V.
    Denkert, C.
    Untch, M.
    ANNALS OF ONCOLOGY, 2022, 33 (11) : 1149 - 1158
  • [2] The prognosis of effectiveness neoadjuvant therapy in patients with triple-negative breast cancer
    Vyzhigina, B.
    BREAST, 2019, 44 : S67 - S67
  • [3] The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.
    Nakano, E.
    Hojo, T.
    Masumura, K.
    Kikuyama, M.
    Akashi, S.
    Kinoshita, T.
    CANCER RESEARCH, 2009, 69 (02) : 337S - 337S
  • [4] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    PLOS ONE, 2016, 11 (12):
  • [5] BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Sengoku, Norihiko
    Waraya, Mina
    Nishimiya, Hiroshi
    Katoh, Hirozhi
    Kikuchi, Mariko
    Minatani, Naoko
    Teraoka, Saeko
    Enomoto, Takumo
    Sato, Takeo
    Masahiko, Masahiko
    CANCER RESEARCH, 2015, 75
  • [6] Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models
    Hongyan Zheng
    Lihua Wu
    Jianfeng Chen
    Na Na
    Ge Lou
    Breast Cancer, 2024, 31 : 371 - 381
  • [7] Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models
    Zheng, Hongyan
    Wu, Lihua
    Chen, Jianfeng
    Na, Na
    Lou, Ge
    BREAST CANCER, 2024, 31 (03) : 371 - 381
  • [8] Immunological and clinical consequences of durvalumab treatment in combination to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Massa, Chiara
    Karn, Thomas
    Weber, Karsten
    Schneeweiss, Andreas
    Hanusch, Claus
    Blohmer, Jens-Uwe
    Zahm, Dirk-Michael
    Jackisch, Christian
    van Mackelenbergh, Marion
    Thomalla, Jorg
    Marme, Frederik
    Huober, Jens
    Mueller, Volkmar
    Schem, Christian
    Mueller, Anja
    Stickeler, Elmar
    Biehl, Katharina
    Fasching, Peter A.
    Untch, Michael
    Loibl, Sibylle
    Denkert, Carsten
    Seliger, Barbara
    CANCER RESEARCH, 2023, 83 (05)
  • [9] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Masuda, Hiroko
    Masuda, Norikazu
    Kodama, Yoshinori
    Ogawa, Masami
    Karita, Michiko
    Yamamura, Jun
    Tsukuda, Kazunori
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    Mano, Masayuki
    Nakamori, Shoji
    Tsujinaka, Toshimasa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 911 - 917
  • [10] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
12345